-
1
-
-
70350279315
-
Atypical hemolytic-uremic syndrome
-
Noris M, Remuzzi G., Atypical hemolytic-uremic syndrome. N Engl J Med 2009; 361: 1676-1687.
-
(2009)
N Engl J Med
, vol.361
, pp. 1676-1687
-
-
Noris, M.1
Remuzzi, G.2
-
2
-
-
15244348050
-
Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome
-
Tarr PI, Gordon CA, Chandler WL., Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome. Lancet 2005; 365: 1073-1086.
-
(2005)
Lancet
, vol.365
, pp. 1073-1086
-
-
Tarr, P.I.1
Gordon, C.A.2
Chandler, W.L.3
-
3
-
-
77957550498
-
Complement in typical hemolytic uremic syndrome
-
Orth D, Wurzner R., Complement in typical hemolytic uremic syndrome. Semin Thromb Hemost 2010; 36: 620-624.
-
(2010)
Semin Thromb Hemost
, vol.36
, pp. 620-624
-
-
Orth, D.1
Wurzner, R.2
-
4
-
-
0027185787
-
Endothelial heterogeneity in Shiga toxin receptors and responses
-
Obrig TG, Louise CB, Lingwood CA, Boyd B, Barley-Maloney L, Daniel TO., Endothelial heterogeneity in Shiga toxin receptors and responses. J Biol Chem 1993; 268: 15484-15488.
-
(1993)
J Biol Chem
, vol.268
, pp. 15484-15488
-
-
Obrig, T.G.1
Louise, C.B.2
Lingwood, C.A.3
Boyd, B.4
Barley-Maloney, L.5
Daniel, T.O.6
-
5
-
-
80053645340
-
A new health threat in Europe: Shiga toxin-producing Escherichia coli O104: H4 infections
-
Wu CJ, Hsueh PR., Ko WC., A new health threat in Europe: Shiga toxin-producing Escherichia coli O104: H4 infections. J Microbiol Immunol Infect 2011; 44: 390-393.
-
(2011)
J Microbiol Immunol Infect
, vol.44
, pp. 390-393
-
-
Wu, C.J.1
Hsueh, P.R.2
Ko, W.C.3
-
6
-
-
0034980687
-
Effect of Shiga toxin and Shiga-like toxins on eukaryotic cells
-
O'Loughlin EV, Robins-Browne RM., Effect of Shiga toxin and Shiga-like toxins on eukaryotic cells. Microb Infect 2001; 3: 493-507.
-
(2001)
Microb Infect
, vol.3
, pp. 493-507
-
-
O'Loughlin, E.V.1
Robins-Browne, R.M.2
-
7
-
-
18744414483
-
Shiga toxin-2 triggers endothelial leukocyte adhesion and transmigration via NF-kappaB dependent up-regulation of IL-8 and MCP-1
-
Zoja C, Angioletti S, Donadelli R, et al. Shiga toxin-2 triggers endothelial leukocyte adhesion and transmigration via NF-kappaB dependent up-regulation of IL-8 and MCP-1. Kidney Int 2002; 62: 846-856.
-
(2002)
Kidney Int
, vol.62
, pp. 846-856
-
-
Zoja, C.1
Angioletti, S.2
Donadelli, R.3
-
8
-
-
0035885951
-
Verotoxin-1-induced up-regulation of adhesive molecules renders microvascular endothelial cells thrombogenic at high shear stress
-
Morigi M, Galbusera M, Binda E, et al. Verotoxin-1-induced up-regulation of adhesive molecules renders microvascular endothelial cells thrombogenic at high shear stress. Blood 2001; 98: 1828-1835.
-
(2001)
Blood
, vol.98
, pp. 1828-1835
-
-
Morigi, M.1
Galbusera, M.2
Binda, E.3
-
9
-
-
0041411081
-
Long-term renal prognosis of diarrhea-associated hemolytic uremic syndrome: A systematic review of meta-analysis, and meta-regression
-
Garg AX, Suri RS, Barrowman N, et al. Long-term renal prognosis of diarrhea-associated hemolytic uremic syndrome: A systematic review of meta-analysis, and meta-regression. JAMA 2003; 290: 1360-1370.
-
(2003)
JAMA
, vol.290
, pp. 1360-1370
-
-
Garg, A.X.1
Suri, R.S.2
Barrowman, N.3
-
10
-
-
38349172121
-
Membrane cofactor protein mutations in atypical hemolytic uremic syndrome (aHUS), fatal Stx-HUS, C3 glomerulonephritis, and the HELLP syndrome
-
Fang CJ, Fremeaux-Bacchi V, Liszewski MK, et al. Membrane cofactor protein mutations in atypical hemolytic uremic syndrome (aHUS), fatal Stx-HUS, C3 glomerulonephritis, and the HELLP syndrome. Blood 2008; 111: 624-632.
-
(2008)
Blood
, vol.111
, pp. 624-632
-
-
Fang, C.J.1
Fremeaux-Bacchi, V.2
Liszewski, M.K.3
-
11
-
-
77958587405
-
Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype
-
Noris M, Caprioli J, Bresin E, et al. Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype. Clin J Am Soc Nephrol 2010; 5: 1844-1859.
-
(2010)
Clin J Am Soc Nephrol
, vol.5
, pp. 1844-1859
-
-
Noris, M.1
Caprioli, J.2
Bresin, E.3
-
12
-
-
67651166873
-
Mutations in thrombomodulin in hemolytic-uremic syndrome
-
Delvaeye M, Noris M, DeVriese A, et al. Mutations in thrombomodulin in hemolytic-uremic syndrome. N Engl J Med 2009; 361: 345-357.
-
(2009)
N Engl J Med
, vol.361
, pp. 345-357
-
-
Delvaeye, M.1
Noris, M.2
Devriese, A.3
-
13
-
-
75649133611
-
Association of factor H autoantibodies with deletions of CFHR1, CFHR3, CFHR4, and with mutations in CFH, CFI, CD46, and C3 in patients with atypical hemolytic uremic syndrome
-
Moore I, Strain L, Pappworth I, et al. Association of factor H autoantibodies with deletions of CFHR1, CFHR3, CFHR4, and with mutations in CFH, CFI, CD46, and C3 in patients with atypical hemolytic uremic syndrome. Blood 2010; 115: 379-387.
-
(2010)
Blood
, vol.115
, pp. 379-387
-
-
Moore, I.1
Strain, L.2
Pappworth, I.3
-
14
-
-
34047200899
-
Deletion of complement factor H-related genes CFHR1 and CFHR3 is associated with atypical hemolytic uremic syndrome
-
Zipfel PF, Edey M, Heinen S, et al. Deletion of complement factor H-related genes CFHR1 and CFHR3 is associated with atypical hemolytic uremic syndrome. PLoS Genet 2007; 3: e41.
-
(2007)
PLoS Genet
, vol.3
-
-
Zipfel, P.F.1
Edey, M.2
Heinen, S.3
-
15
-
-
20544437666
-
Anti-factor H autoantibodies associated with atypical hemolytic uremic syndrome
-
Dragon-Durey MA, Loirat C, Cloarec S, et al. Anti-factor H autoantibodies associated with atypical hemolytic uremic syndrome. J Am Soc Nephrol 2005; 16: 555-563.
-
(2005)
J Am Soc Nephrol
, vol.16
, pp. 555-563
-
-
Dragon-Durey, M.A.1
Loirat, C.2
Cloarec, S.3
-
16
-
-
67650508077
-
The high frequency of complement factor H-related CFHR1 gene deletion is restricted to specific subgroups of patients with atypical haemolytic uraemic syndrome
-
Dragon-Durey MA, Blanc C, Marliot F, et al. The high frequency of complement factor H-related CFHR1 gene deletion is restricted to specific subgroups of patients with atypical haemolytic uraemic syndrome. J Med Genet 2009; 46: 447-450.
-
(2009)
J Med Genet
, vol.46
, pp. 447-450
-
-
Dragon-Durey, M.A.1
Blanc, C.2
Marliot, F.3
-
17
-
-
33846668749
-
Hemolytic uremic syndrome: A factor H mutation (E1172Stop) causes defective complement control at the surface of endothelial cells
-
Heinen S, Jozsi M, Hartmann A, et al. Hemolytic uremic syndrome: A factor H mutation (E1172Stop) causes defective complement control at the surface of endothelial cells. J Am Soc Nephrol 2007; 18: 506-514.
-
(2007)
J Am Soc Nephrol
, vol.18
, pp. 506-514
-
-
Heinen, S.1
Jozsi, M.2
Hartmann, A.3
-
18
-
-
0035810399
-
Complement first of two parts
-
Walport MJ., Complement first of two parts. N Engl J Med 2001; 344: 1058-1066.
-
(2001)
N Engl J Med
, vol.344
, pp. 1058-1066
-
-
Walport, M.J.1
-
19
-
-
84867997580
-
STEC-HUS, atypical HUS and TTP are all diseases of complement activation
-
Noris M, Mescia F, Remuzzi G., STEC-HUS, atypical HUS and TTP are all diseases of complement activation. Nat Rev Nephrol 2012; 8: 622-633.
-
(2012)
Nat Rev Nephrol
, vol.8
, pp. 622-633
-
-
Noris, M.1
Mescia, F.2
Remuzzi, G.3
-
20
-
-
77954048044
-
Thrombotic microangiopathy after kidney transplantation
-
Noris M, Remuzzi G., Thrombotic microangiopathy after kidney transplantation. Am J Transplant 2010; 10: 1517-1523.
-
(2010)
Am J Transplant
, vol.10
, pp. 1517-1523
-
-
Noris, M.1
Remuzzi, G.2
-
21
-
-
0030049869
-
Bilateral nephrectomy stopped disease progression in plasma-resistant hemolytic uremic syndrome with neurological signs and coma
-
Remuzzi G, Galbusera M, Salvadori M, Rizzoni G, Paris S, Ruggenenti P., Bilateral nephrectomy stopped disease progression in plasma-resistant hemolytic uremic syndrome with neurological signs and coma. Kidney Int 1996; 49: 282-286.
-
(1996)
Kidney Int
, vol.49
, pp. 282-286
-
-
Remuzzi, G.1
Galbusera, M.2
Salvadori, M.3
Rizzoni, G.4
Paris, S.5
Ruggenenti, P.6
-
22
-
-
79960446438
-
Complement factor i in health and disease
-
Nilsson SC, Sim RB, Lea SM, Fremeaux-Bacchi V, Blom AM., Complement factor I in health and disease. Mol Immunol 2011; 48: 1611-1620.
-
(2011)
Mol Immunol
, vol.48
, pp. 1611-1620
-
-
Nilsson, S.C.1
Sim, R.B.2
Lea, S.M.3
Fremeaux-Bacchi, V.4
Blom, A.M.5
-
23
-
-
33745812440
-
Genetic and functional analyses of membrane cofactor protein (CD46) mutations in atypical hemolytic uremic syndrome
-
Fremeaux-Bacchi V, Moulton EA, Kavanagh D, et al. Genetic and functional analyses of membrane cofactor protein (CD46) mutations in atypical hemolytic uremic syndrome. J Am Soc Nephrol 2006; 17: 2017-2025.
-
(2006)
J Am Soc Nephrol
, vol.17
, pp. 2017-2025
-
-
Fremeaux-Bacchi, V.1
Moulton, E.A.2
Kavanagh, D.3
-
24
-
-
77952682366
-
Mutations in alternative pathway complement proteins in American patients with atypical hemolytic uremic syndrome
-
Maga TK, Nishimura CJ, Weaver AE, Frees KL, Smith RJ., Mutations in alternative pathway complement proteins in American patients with atypical hemolytic uremic syndrome. Hum Mutat 2010; 31: E1445-E1460.
-
(2010)
Hum Mutat
, vol.31
-
-
Maga, T.K.1
Nishimura, C.J.2
Weaver, A.E.3
Frees, K.L.4
Smith, R.J.5
-
25
-
-
0036952936
-
Shiga toxin-associated hemolytic uremic syndrome: Absence of recurrence after renal transplantation
-
Ferraris JR, Ramirez JA, Ruiz S, et al. Shiga toxin-associated hemolytic uremic syndrome: Absence of recurrence after renal transplantation. Pediatr Nephrol 2002; 17: 809-814.
-
(2002)
Pediatr Nephrol
, vol.17
, pp. 809-814
-
-
Ferraris, J.R.1
Ramirez, J.A.2
Ruiz, S.3
-
26
-
-
0026666338
-
Hypocomplementemia and leukocytosis in diarrhea-associated hemolytic uremic syndrome
-
Robson WL, Leung AK, Fick GH, McKenna AI., Hypocomplementemia and leukocytosis in diarrhea-associated hemolytic uremic syndrome. Nephron 1992; 62: 296-299.
-
(1992)
Nephron
, vol.62
, pp. 296-299
-
-
Robson, W.L.1
Leung, A.K.2
Fick, G.H.3
McKenna, A.I.4
-
27
-
-
79960435714
-
Alternative pathway activation of complement by Shiga toxin promotes exuberant C3a formation that triggers microvascular thrombosis
-
Morigi M, Galbusera M, Gastoldi S, et al. Alternative pathway activation of complement by Shiga toxin promotes exuberant C3a formation that triggers microvascular thrombosis. J Immunol 2011; 187: 172-180.
-
(2011)
J Immunol
, vol.187
, pp. 172-180
-
-
Morigi, M.1
Galbusera, M.2
Gastoldi, S.3
-
29
-
-
80052473232
-
Prophylactic eculizumab prior to kidney transplantation for atypical hemolytic uremic syndrome
-
Weitz M, Amon O, Bassler D, Koenigsrainer A, Nadalin S., Prophylactic eculizumab prior to kidney transplantation for atypical hemolytic uremic syndrome. Pediatr Nephrol 2011; 26: 1325-1329.
-
(2011)
Pediatr Nephrol
, vol.26
, pp. 1325-1329
-
-
Weitz, M.1
Amon, O.2
Bassler, D.3
Koenigsrainer, A.4
Nadalin, S.5
-
30
-
-
77951876953
-
Prophylactic eculizumab after renal transplantation in atypical hemolytic-uremic syndrome
-
Zimmerhackl LB, Hofer J, Cortina G, et al. Prophylactic eculizumab after renal transplantation in atypical hemolytic-uremic syndrome. N Engl J Med 2010; 362: 1746-1748.
-
(2010)
N Engl J Med
, vol.362
, pp. 1746-1748
-
-
Zimmerhackl, L.B.1
Hofer, J.2
Cortina, G.3
|